H2 Blockers
- PMID: 30252250
- Bookshelf ID: NBK525994
H2 Blockers
Excerpt
H2 receptor blockers, or histamine-2 receptor antagonists (H2RAs), are gastric acid-suppressing agents frequently used to treat various gastric conditions. The U.S. Food and Drug Administration has approved the short-term administration of H2RAs for patients with uncomplicated gastroesophageal reflux disease (GERD), gastric or duodenal ulcers, gastric hypersecretion, and mild to infrequent heartburn or indigestion. H2RAs may also be used off-label for stress ulcer prophylaxis, esophagitis, gastritis, gastrointestinal bleeding, or urticaria. H2RAs are sometimes part of a multidrug regimen for Helicobacter pylori eradication.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Pappa KA, Williams BO, Payne JE, Buaron KS, Mussari KL, Ciociola AA. A double-blind, placebo-controlled study of the efficacy and safety of non-prescription ranitidine 75 mg in the prevention of meal-induced heartburn. Aliment Pharmacol Ther. 1999 Apr;13(4):467-73. - PubMed
-
- Strauss DG, Florian J, Keire D. Risk of N-Nitrosodimethylamine (NMDA) Formation With Ranitidine. JAMA. 2021 Nov 23;326(20):2077. - PubMed
-
- Laine L, Barkun AN, Saltzman JR, Martel M, Leontiadis GI. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol. 2021 May 01;116(5):899-917. - PubMed
Publication types
LinkOut - more resources
Full Text Sources